ArticleFolia microbiologica2026
Antileishmanial, antioxidant and anti-hemolytic activities of green synthesized ZnO nanoparticles mediated by Teucrium stocksianum Boiss leaf extract.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous leishmaniasis is the most common form of the vector borne parasitic disease, causing skin lesion and ulcer. Several studies have reported the resistance of cutaneous leishmaniasis parasite to antimonial drugs. Hence, there is a need to develop cheaper and effective alternative therapies for resistance breakdown. In the current study we report the effectiveness of Teucrium stocksianum extract mediated green synthesized zinc oxide nanoparticles (ZnONPs) against Leishmania tropica (KMU25), a causative species of cutaneous leishmanaisis. ZnONPs was successfully synthesised at 70 °C by continuous stirring (2 h) of aqueous extract (5 mg/mL) and Zinc acetate solution (2 g/50 mL, pH: 8) in 1:9. The characterization of these NPs showed a UV-Vis surface plasmon resonance at 365 nm, hexagonal morphology with irregular shapes through scanning electron microscopy, average crystal size 21.48 ± 5.2 nm through XRD analysis and the complex metabolites attachments to the surface of the particles was confirmed by FTIR. The DPPH (2,2-diphenyl-1-picrylhydrazyl) assay-based antioxidant activity showed 50% free radical scavenging at 624.94 µg/mL and 798.45 µg/mL for extract and ZnONPs, respectively. The hemolysis assay revealed moderate cytotoxicity with a LD
Indexed as
Identifiers
41493711What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.